BioTelemetry
BioTelemetry provides advanced cardiac monitoring solutions, including MCOT, ePatch, and Implantable Device Monitoring, and processes over 4 billion heartbeats daily. Acquired by Philips in 2021, BioTelemetry integrates with various EMR systems and supports telehealth initiatives.
Services
BioTelemetry provides a comprehensive range of remote cardiac monitoring solutions. These services include Mobile Cardiac Outpatient Telemetry (MCOT), Extended Holter monitoring (ePatch), and Implantable Device Monitoring. The company’s offerings are designed to enhance patient comfort and improve diagnostic accuracy. Additionally, BioTelemetry supports chronic condition management through its Virtual Care Management program, featuring connected devices for monitoring blood glucose, blood pressure, weight, and oxygen saturation.
Key Technology
BioTelemetry’s MCOT is powered by SmartDetectAI, which delivers near real-time arrhythmia analysis and boasts a high diagnostic yield. The company’s ePatch technology enables continuous Holter recording for up to 14 days. BioTelemetry has also implemented a TAVR Home Monitoring Pathway and a Post-Cryptogenic Stroke Pathway, each aimed at specific cardiac conditions. These pathways assist in the detection of delayed high-grade heart block post-TAVR and atrial fibrillation in stroke patients, respectively. BioTelemetry has invested over $300 million in its technology and service platform, contributing to the efficiency and reliability of its monitoring solutions.
Data Network and Patient Reach
BioTelemetry has built the world's largest cardiac data network, processing over 4 billion heartbeats daily. The company monitors over 1 million patients per year with its fleet of more than 50,000 monitoring devices. This extensive network and large-scale data processing capability ensure that BioTelemetry remains a leader in cardiac monitoring technology.
Industry Collaborations
BioTelemetry’s solutions integrate seamlessly with various Electronic Medical Record (EMR) systems including Allscripts, Cerner, EPIC, and Philips IntelliSpace ECG. These collaborations ensure that BioTelemetry’s data and analyses are easily accessible within the existing healthcare infrastructure, facilitating better patient management and care.
Corporate History
Founded in 1994, BioTelemetry has steadily grown to become a significant player in the remote medical technology services industry. The company specializes in cardiac monitoring, centralized medical imaging, and original equipment manufacturing. In February 2021, BioTelemetry was acquired by Philips and integrated into Philips' Connected Care business segment. This acquisition has further strengthened BioTelemetry’s market position and expanded its technological capabilities.